Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas

被引:69
|
作者
Yoon, Jiyoung [1 ]
Suh, Young Joo [1 ]
Han, Kyunghwa [1 ]
Cho, Hyoun [1 ]
Lee, Hye-Jeong [1 ]
Hur, Jin [1 ]
Choi, Byoung Wook [1 ]
机构
[1] Yonsei Univ, Severance Hosp, Coll Med, Res Inst Radiol Sci,Dept Radiol, Seoul, South Korea
关键词
Computed tomography; immunotherapy; lung adenocarcinoma; programmed death ligand 1; radiomics; FACTOR RECEPTOR MUTATION; DEATH LIGAND 1; EGFR MUTATION; INTERNATIONAL ASSOCIATION; COMPUTED-TOMOGRAPHY; TEXTURE ANALYSIS; STAGE-I; CANCER; CLASSIFICATION; FEATURES;
D O I
10.1111/1759-7714.13352
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background We aimed to assess if quantitative radiomic features can predict programmed death ligand 1 (PD-L1) expression in advanced stage lung adenocarcinoma. Methods This retrospective study included 153 patients who had advanced stage (>IIIA by TNM classification) lung adenocarcinoma with pretreatment thin section computed tomography (CT) images and PD-L1 expression test results in their pathology reports. Clinicopathological data were collected from electronic medical records. Visual analysis and radiomic feature extraction of the tumor from pretreatment CT were performed. We constructed two models for multivariate logistic regression analysis (one based on clinical variables, and the other based on a combination of clinical variables and radiomic features), and compared c-statistics of the receiver operating characteristic curves of each model to identify the model with the higher predictability. Results Among 153 patients, 53 patients were classified as PD-L1 positive and 100 patients as PD-L1 negative. There was no significant difference in clinical characteristics or imaging findings on visual analysis between the two groups (P > 0.05 for all). Rad-score by radiomic analysis was higher in the PD-L1 positive group than in the PD-L1 negative group with a statistical significance (-0.378 +/- 1.537 vs. -1.171 +/- 0.822, P = 0.0008). A prediction model that uses clinical variables and CT radiomic features showed higher performance compared to a prediction model that uses clinical variables only (c-statistic = 0.646 vs. 0.550, P = 0.0299). Conclusions Quantitative CT radiomic features can predict PD-L1 expression in advanced stage lung adenocarcinoma. A prediction model composed of clinical variables and CT radiomic features may facilitate noninvasive assessment of PD-L1 expression. Key points Significant findings of the study Quantitative CT radiomic features can help predict PD-L1 expression, whereas none of the qualitative imaging findings is associated with PD-L1 positivity. What this study adds A prediction model composed of clinical variables and CT radiomic features may facilitate noninvasive assessment of PD-L1 expression.
引用
收藏
页码:993 / 1004
页数:12
相关论文
共 50 条
  • [1] CT-based radiomics for prediction of PD-L1 expression in urothelial carcinoma
    Ku, J. Y.
    Seo, Y. J.
    Kim, K. H.
    Kim, S. D.
    Hwang, E. C.
    Ha, H. K.
    EUROPEAN UROLOGY, 2023, 83 : S849 - S850
  • [2] Prediction of PD-L1 expression rate in non-small cell lung cancer based on CT-radiomics
    Xi, Lihong
    Yang, Lingya
    He, Xiaofeng
    Huang, Jingling
    Li, Jun
    Zhong, Daquan
    Huang, Haipeng
    Li, Jiabin
    Zhai, Tiantian
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S5015 - S5019
  • [3] Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas
    Schoenfeld, A. J.
    Rizvi, H.
    Bandlamudi, C.
    Sauter, J. L.
    Travis, W. D.
    Rekhtman, N.
    Plodkowski, A. J.
    Perez-Johnston, R.
    Sawan, P.
    Beras, A.
    Egger, J. V.
    Ladanyi, M.
    Arbour, K. C.
    Rudin, C. M.
    Riely, G. J.
    Taylor, B. S.
    Donoghue, M. T. A.
    Hellmann, M. D.
    ANNALS OF ONCOLOGY, 2020, 31 (05) : 599 - 608
  • [4] Heterogeneity of PD-L1 Expression in Lung Mixed Adenocarcinomas and Adenosquamous Carcinomas
    Zito Marino, Federica
    Rossi, Giulio
    Montella, Marco
    Botti, Gerardo
    De Cecio, Rossella
    Morabito, Alessandro
    La Manna, Carmine
    Ronchi, Andrea
    Micheli, Mariacarolina
    Salatiello, Giuseppe
    Micheli, Pietro
    Rocco, Danilo
    Accardo, Marina
    Franco, Renato
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (03) : 378 - 386
  • [5] Heterogeneity of PD-L1 expression between invasive and lepidic components of lung adenocarcinomas
    Antonious Hazim
    Neil Majithia
    Stephen J. Murphy
    Dennis Wigle
    Marie-Christine Aubry
    Aaron S. Mansfield
    Cancer Immunology, Immunotherapy, 2021, 70 : 2651 - 2656
  • [6] PD-L1 Expression Is Associated with KRAS and BRAF Mutations in Primary Lung Adenocarcinomas
    Minerowicz, Christine
    Miller, Caitlyn
    Dacic, Sanja
    MODERN PATHOLOGY, 2017, 30 : 484A - 484A
  • [7] Heterogeneity of PD-L1 expression between invasive and lepidic components of lung adenocarcinomas
    Majithia, N.
    Aubry, M. C.
    Murphy, S.
    Mansfield, A. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (01): : 237 - 238
  • [8] PD-L1 Expression Is Associated with KRAS and BRAF Mutations in Primary Lung Adenocarcinomas
    Minerowicz, Christine
    Miller, Caitlyn
    Dacic, Sanja
    LABORATORY INVESTIGATION, 2017, 97 : 484A - 484A
  • [9] Heterogeneity of PD-L1 expression between invasive and lepidic components of lung adenocarcinomas
    Hazim, Antonious
    Majithia, Neil
    Murphy, Stephen J.
    Wigle, Dennis
    Aubry, Marie-Christine
    Mansfield, Aaron S.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (09) : 2651 - 2656
  • [10] Mutational Analysis in Pulmonary Adenocarcinomas with PD-L1 Expression
    Setoodeh, Reza
    Walts, Ann
    Makhoul, Elias
    Marchevsky, Alberto
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1816 - 1817